Brivanib
- Generic Name
- Brivanib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H19FN4O3
- CAS Number
- 649735-46-6
- Unique Ingredient Identifier
- DDU33B674I
- Background
Brivanib is under investigation for the treatment of HepatoCellular Carcinoma. Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath